本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altamira Therapeutics Ltd.

0.1000
0.0000
成交量:68.00
成交額:6.46
市值:57.16萬
市盈率:-0.08
高:0.1000
開:0.1000
低:0.1000
收:0.1000
52周最高:0.1600
52周最低:0.0501
股本:571.55萬
流通股本:464.21萬
量比:0.07
換手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-1.1900
每股收益(LYR):-2.9862
淨資產收益率:-108.79%
總資產收益率:-45.75%
市淨率:0.14
市盈率(LYR):-0.03

資料載入中...

2025/06/17

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/16

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/16

SEC問詢函

Form CORRESP - Correspondence
2024/09/16

SEC問詢函

Form CORRESP - Correspondence
2024/08/22

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/01

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/22

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/16

SEC問詢函

Form CORRESP - Correspondence
2024/04/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/01/17

SEC問詢函

Form CORRESP - Correspondence